Evidence map›Paper›PMID 25692475›Full record

ArticlePLoS genetics2015

Fatty acid synthase cooperates with glyoxalase 1 to protect against sugar toxicity.

Damien Garrido, Thomas Rubin, Mickael Poidevin, Brigitte Maroni, Arnaud Le Rouzic, Jean-Philippe Parvy, Jacques Montagne

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 112 citations in OpenAlex.

  1. Lipid Metabolism in Relation to Carbohydrate Metabolism.Advances in experimental medicine and biology · 2026
    Review
  2. Dietary Lipids and Their Metabolism in the Midgut.Advances in experimental medicine and biology · 2026
    Review
  3. Insect Lipidomics: Advances, Applications, and Physiological Insights.Advances in experimental medicine and biology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. From worms to humans: Understanding intestinal lipid metabolism via model organisms.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2023
    Review
  16. Article
  17. Article
  18. Open biology · 2022
    Article
  19. eLife · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Damien GarridoUniversité Paris-Sud 11, Orsay, France; CNRS, Centre de Génétique Moléculaire, UPR 3404, Gif-sur-Yvette, France.
Thomas RubinUniversité Paris-Sud 11, Orsay, France; CNRS, Centre de Génétique Moléculaire, UPR 3404, Gif-sur-Yvette, France.
Mickael PoidevinUniversité Paris-Sud 11, Orsay, France; CNRS, Centre de Génétique Moléculaire, UPR 3404, Gif-sur-Yvette, France.
Brigitte MaroniUniversité Paris-Sud 11, Orsay, France; CNRS, Centre de Génétique Moléculaire, UPR 3404, Gif-sur-Yvette, France.
Arnaud Le RouzicUniversité Paris-Sud 11, Orsay, France; CNRS, Laboratorie Evolution Genome et Speciation, UPR 9034, Gif-sur-Yvette, France.
Jean-Philippe ParvyUniversité Paris-Sud 11, Orsay, France; CNRS, Centre de Génétique Moléculaire, UPR 3404, Gif-sur-Yvette, France.
Jacques MontagneUniversité Paris-Sud 11, Orsay, France; CNRS, Centre de Génétique Moléculaire, UPR 3404, Gif-sur-Yvette, France.
Centre National de la Recherche Scientifique · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty acid (FA) metabolism is deregulated in several human diseases including metabolic syndrome, type 2 diabetes and cancers. Therefore, FA-metabolic enzymes are potential targets for drug therapy, although the consequence of these treatments must be precisely evaluated at the organismal and cellular levels. In healthy organism, synthesis of triacylglycerols (TAGs)-composed of three FA units esterified to a glycerol backbone-is increased in response to dietary sugar. Saturation in the storage and synthesis capacity of TAGs is associated with type 2 diabetes progression. Sugar toxicity likely depends on advanced-glycation-end-products (AGEs) that form through covalent bounding between amine groups and carbonyl groups of sugar or their derivatives α-oxoaldehydes. Methylglyoxal (MG) is a highly reactive α-oxoaldehyde that is derived from glycolysis through a non-enzymatic reaction. Glyoxalase 1 (Glo1) works to neutralize MG, reducing its deleterious effects. Here, we have used the power of Drosophila genetics to generate Fatty acid synthase (FASN) mutants, allowing us to investigate the consequence of this deficiency upon sugar-supplemented diets. We found that FASN mutants are lethal but can be rescued by an appropriate lipid diet. Rescued animals do not exhibit insulin resistance, are dramatically sensitive to dietary sugar and accumulate AGEs. We show that FASN and Glo1 cooperate at systemic and cell-autonomous levels to protect against sugar toxicity. We observed that the size of FASN mutant cells decreases as dietary sucrose increases. Genetic interactions at the cell-autonomous level, where glycolytic enzymes or Glo1 were manipulated in FASN mutant cells, revealed that this sugar-dependent size reduction is a direct consequence of MG-derived-AGE accumulation. In summary, our findings indicate that FASN is dispensable for cell growth if extracellular lipids are available. In contrast, FA-synthesis appears to be required to limit a cell-autonomous accumulation of MG-derived-AGEs, supporting the notion that MG is the most deleterious α-oxoaldehyde at the intracellular level.

Indexed as

AnimalsDiabetes Mellitus, Type 2Dietary SucroseDrosophilaFatty Acid Synthase, Type IGlycation End Products, AdvancedHumansInsulin ResistanceLactoylglutathione LyaseLipidsMetabolic SyndromeMutationNeoplasmsPyruvaldehydeTriglyceridesDietary SucroseFatty Acid Synthase, Type IGlycation End Products, AdvancedLactoylglutathione LyaseLipidsPyruvaldehydeTriglycerides

Identifiers

PMID25692475
PMCPMC4334898
OpenAlexW1985246079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.